New rare disease center aims to make gene therapy routine for neglected patients

A new nonprofit organisation has launched to streamline the development of gene therapies for rare diseases that pharmaceutical companies typically overlook. Its goal is to make treatment more like a routine procedure rather than a bespoke drug developed from scratch each time. The initiative aims to give patients with uncommon conditions better access to effective therapies.